drugset / Trial / NCT04056923

3D Printing for Nodule Localization

NCT04056923

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Implementation of lung cancer screening using low-dose computed tomography has increased the rate of detection of small peripheral pulmonary nodules. However, it is hard to localize these nodules by palpation because of their small volume and long distance to the nearest pleural surface. To further clarify the confounding factors, we developed our own 3D printing localization procedure. In contrast to traditional CT-G percutaneous puncture localization, our procedure was performed in the operating room without CT scan evaluation.

Timeline

Start
2018-01-01
Primary completion
2018-06-07
Completion
2018-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Indocyanine Green Diagnostic / imaging agent
Subject Methylene Blue Diagnostic / imaging agent